Picture of Biosyent logo

RX Biosyent Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual cashflow statement for Biosyent, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
C2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5.215.714.373.86.28
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1.82.10.9280.1220.18
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.853-1.8-0.942.49-2.18
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6.556.294.46.894.67
Capital Expenditures-0.091-0.068-0.504-0.014-0.085
Purchase of Fixed Assets
Other Investing Cash Flow Items-6.95-1.52-0.8113.4-4.75
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-7.04-1.58-1.323.39-4.84
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.111-0.505-6.39-3.37-2.08
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.4044.18-3.396.85-2.26

Or unlock with your email

Or unlock with your email